Phenotype Summary

Phenotypes

Publication	Data		Phenotype
Yan et al., 2017	Fig. 3		common bile duct cell population proliferation increased occurrence, abnormal common bile duct hyperplastic, abnormal common bile duct increased circumference, abnormal hepatocyte tgfb1a expression increased amount, abnormal hepatocyte ab1-tgfb1a labeling increased amount, abnormal hepatocyte hyperplastic, abnormal hepatocyte mCherry expression increased amount, abnormal liver cholangiocarcinoma increased amount, abnormal liver hepatocellular adenoma increased amount, abnormal liver hepatocellular carcinoma increased amount, abnormal liver neoplastic, abnormal
	Fig. 4		hepatocyte Ab12-smad2 labeling increased amount, abnormal hepatocyte ab26-mapk labeling increased amount, abnormal
	Fig. 5		common bile duct hyperplastic, ameliorated hepatocyte Ab12-smad2 labeling increased amount, abnormal hepatocyte ab26-mapk labeling amount, ameliorated hepatocyte ab26-mapk labeling increased amount, abnormal hepatocyte hyperplastic, abnormal liver ab1-casp3 labeling amount, ameliorated liver ab1-casp3 labeling increased amount, abnormal liver ab5-pcna labeling amount, ameliorated liver ab5-pcna labeling increased amount, abnormal liver cell death increased occurrence, abnormal liver cell death increased occurrence, ameliorated liver cell death increased occurrence, exacerbated liver cell population proliferation increased occurrence, abnormal liver cell population proliferation increased occurrence, ameliorated liver cell population proliferation increased occurrence, exacerbated liver cholangiocarcinoma increased amount, abnormal liver cholangiocarcinoma increased amount, ameliorated liver cholangiocyte Ab12-smad2 labeling amount, ameliorated liver cholangiocyte Ab12-smad2 labeling increased amount, abnormal liver cholangiocyte ab26-mapk labeling amount, ameliorated liver cholangiocyte ab26-mapk labeling increased amount, abnormal liver hepatocellular adenoma increased amount, abnormal liver hepatocellular carcinoma increased amount, abnormal liver neoplastic, abnormal liver neoplastic, ameliorated
	Fig. 6		liver ab1-casp3 labeling increased amount, abnormal liver Ab12-smad2 labeling increased amount, abnormal liver ab26-mapk labeling increased amount, abnormal liver Ab8-smad2 labeling increased amount, abnormal